

Related Articles
Beware tacit collusion: price transparency has its own pitfalls
“Curing High Healthcare Prices” By Robert Graboyes and Jessica McBirney, courtesy of the Mercatus Center For the majority of Americans, the cost of healthcare is a thing of mystery. Go in for a major procedure, and you’ll have no idea what sort of financial statement will waft into your mailbox weeks or months later. […]
Washington Beyond the Headlines: Index Capital Gains to Inflation to Keep Economy Humming
By Andy Blom, TES Washington Editor The Democratic primary gets nastier, coronavirus panics the markets and Congress responds with partisan bickering…. Ho hum, another week of business as usual…except for free market policy people who are busy working on issues and ideas that affect America, and the world. Read on for this week’s […]
IPI Model Will Cause Shortage of Life-Saving Drugs
By Derek Hosford, American Consumer Institute In 2018, the Department of Health and Human Services announced an International Price Index (IPI) would be instituted as part of an effort to bring down Medicare Part B prescription drug costs. The plan would set a limit on the price the government would pay manufacturers for drugs […]